Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk factors

D J Marchant1

  • 1Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts, USA.

Obstetrics and Gynecology Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Identifying culturally acceptable breast cancer risk factor modifications is crucial for prevention. Research is exploring chemopreventive programs and targeted treatments to combat this public health challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Breast Health Center at Women & Infants Hospital: origin, philosophy, and features.

Surgical oncology clinics of North America·2000
Same author

Controversies in benign breast disease.

Surgical oncology clinics of North America·1998
Same author

Contemporary management of breast cancer.

Obstetrics and gynecology clinics of North America·1994
Same author

Making the diagnosis.

Obstetrics and gynecology clinics of North America·1994
Same author

Invasive breast cancer. Surgical treatment alternatives.

Obstetrics and gynecology clinics of North America·1994
Same author

Breast cancer in pregnancy.

Clinical obstetrics and gynecology·1994
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Public Health
  • Cancer Prevention

Background:

  • Breast cancer affects nearly all women in the United States, presenting a significant public health concern.
  • While many diagnosed women do not experience recurrence, effective prevention strategies are needed.
  • Culturally acceptable modifications to breast cancer risk factors remain largely unestablished.

Purpose of the Study:

  • To address the need for established, culturally acceptable breast cancer risk factor modifications.
  • To explore newer strategies for breast cancer prevention, including chemopreventive programs.
  • To investigate targeted treatments for inhibiting growth factors crucial to malignant phenotypes.

Main Methods:

  • Phase III clinical trials are evaluating the efficacy of retinoids and tamoxifen for breast cancer prevention.

Related Experiment Videos

  • Phase I and II studies are assessing treatments designed to inhibit specific growth factors.
  • Research is ongoing to identify and validate culturally acceptable risk factor modifications.

    • Main Results:

    • Ongoing clinical trials are assessing the value of retinoids and tamoxifen.
    • Early-phase studies are investigating targeted therapies for malignant phenotypes.
    • Further research is required to establish culturally acceptable risk factor modifications.

    Conclusions:

    • Effective breast cancer prevention requires the identification of culturally acceptable risk factor modifications.
    • Chemopreventive programs and targeted therapies show promise but require further investigation.
    • Continued research is essential to address breast cancer as a major public health issue.